Loading
Medical oncologist who leads the IUCT Oncopole cooperation group in Toulouse and runs early-phase cancer drug trials.
Jean-Pierre Delord is a professor of medical oncology and the administrator of the healthcare cooperation group (GCS) that runs IUCT Oncopole, the Toulouse university cancer institute combining the Oncopole Claudius Regaud and CHU de Toulouse teams. His research centres on early-phase clinical trials of new cancer drugs, including first-in-human studies such as the netrin-1 antibody programme published in Nature in 2023.
| Title | Journal | Year |
|---|---|---|
| Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer | Nature | 2023 |
Shares Endometrial cancer and the tags leadership, clinician-scientist.
Shares Endometrial cancer and the tags leadership, clinician-scientist.
Shares Head and neck squamous cell carcinoma and the tags leadership, clinician-scientist.
Shares Endometrial cancer and the tags leadership, clinician-scientist.
Shares Endometrial cancer and the tags leadership, clinician-scientist.
Shares Endometrial cancer and the tags leadership, clinician-scientist.
Shares Head and neck squamous cell carcinoma and the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist, medical oncology.